BACKGROUND: We demonstrated previously that tumor necrosis factor α (TNF-α)-producing Chlamydia-specific CD8(+) T cells cause oviduct pathological sequelae. METHODS: In the current study, we used wild-type C57BL/6J (WT) mice with a deficiency in genes encoding TNF receptor superfamily member 1a (TNFR1; TNFR1 knockout [KO] mice), TNF receptor superfamily member 1b (TNFR2; TNFR2 KO mice), and both TNFR1 and TNFR2 (TNFR1/2 double KO [DKO] mice) and mix-match adoptive transfers of CD8(+) T cells to study chlamydial pathogenesis. RESULTS: TNFR1 KO, TNFR2 KO, and TNFR1/2 DKO mice displayed comparable clearance of primary or secondary genital Chlamydia muridarum infection but significantly reduced oviduct pathology, compared with WT animals. The Chlamydia-specific total cellular cytokine response in splenic and draining lymph nodes and the antibody response in serum were comparable between the WT and KO animals. However, CD8(+) T cells from TNFR2 KO mice displayed significantly reduced activation (CD11a expression and cytokine production), compared with TNFR1 KO or WT animals. Repletion of TNFR2 KO mice with WT CD8(+) T cells but not with TNFR2 KO CD8(+) T cells and repletion of TNFR1 KO mice with either WT or TNFR1 KO CD8(+) T cells restored oviduct pathology to WT levels in both KO groups. CONCLUSIONS: Collectively, these results demonstrate that TNFR2-bearing CD8(+) T cells and TNFR1-bearing non-CD8(+) T cells contribute significantly to oviduct pathology following genital chlamydial infection.
BACKGROUND: We demonstrated previously that tumornecrosis factor α (TNF-α)-producing Chlamydia-specific CD8(+) T cells cause oviduct pathological sequelae. METHODS: In the current study, we used wild-type C57BL/6J (WT) mice with a deficiency in genes encoding TNF receptor superfamily member 1a (TNFR1; TNFR1 knockout [KO] mice), TNF receptor superfamily member 1b (TNFR2; TNFR2 KO mice), and both TNFR1 and TNFR2 (TNFR1/2 double KO [DKO] mice) and mix-match adoptive transfers of CD8(+) T cells to study chlamydial pathogenesis. RESULTS:TNFR1 KO, TNFR2 KO, and TNFR1/2 DKO mice displayed comparable clearance of primary or secondary genital Chlamydia muridarum infection but significantly reduced oviduct pathology, compared with WT animals. The Chlamydia-specific total cellular cytokine response in splenic and draining lymph nodes and the antibody response in serum were comparable between the WT and KO animals. However, CD8(+) T cells from TNFR2 KO mice displayed significantly reduced activation (CD11a expression and cytokine production), compared with TNFR1 KO or WT animals. Repletion of TNFR2 KO mice with WT CD8(+) T cells but not with TNFR2 KO CD8(+) T cells and repletion of TNFR1 KO mice with either WT or TNFR1 KO CD8(+) T cells restored oviduct pathology to WT levels in both KO groups. CONCLUSIONS: Collectively, these results demonstrate that TNFR2-bearing CD8(+) T cells and TNFR1-bearing non-CD8(+) T cells contribute significantly to oviduct pathology following genital chlamydial infection.
Authors: J J Peschon; D S Torrance; K L Stocking; M B Glaccum; C Otten; C R Willis; K Charrier; P J Morrissey; C B Ware; K M Mohler Journal: J Immunol Date: 1998-01-15 Impact factor: 5.422
Authors: K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak Journal: Cell Date: 1993-05-07 Impact factor: 41.582
Authors: Laxmi Yeruva; Dakota L Pouncey; Michael R Eledge; Sudeepa Bhattacharya; Chunqiao Luo; Erin W Weatherford; David M Ojcius; Roger G Rank Journal: Infect Immun Date: 2016-12-29 Impact factor: 3.441
Authors: Clare E Gyorke; Manoj K Tripathy; John Allen; Yugen Zhang; Angela Lovett; Stephanie A Montgomery; Uma M Nagarajan Journal: Infect Immun Date: 2019-07-23 Impact factor: 3.441
Authors: Taylor B Poston; De'Ashia E Lee; Toni Darville; Wujuan Zhong; Li Dong; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Gregory D Sempowski; Xiaojing Zheng Journal: J Infect Dis Date: 2019-06-19 Impact factor: 5.226
Authors: Teresa A Batteiger; Nicole Spencer; Charity L Washam; Stephanie Byrum; Michael Eledge; Byron E Batteiger; Roger G Rank; Laxmi Yeruva Journal: Infect Immun Date: 2020-09-18 Impact factor: 3.441
Authors: Stephen J Jordan; Kanupriya Gupta; Brian M O Ogendi; Rakesh K Bakshi; Richa Kapil; Christen G Press; Steffanie Sabbaj; Jeannette Y Lee; William M Geisler Journal: Clin Vaccine Immunol Date: 2017-04-05